Back to search results

Ebastine in Combination With Docetaxel as a Treatment for Castration-resistant Metastatic Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Metastatic Castration-resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Department of Oncology 5073, Rigshospitalet, Copenhagen, Denmark

    Contact: Study coordinator (Helle Pappot, MD, DMSc) · helle.pappot@regionh.dk · 0045 35454222
    Contact: Principal Investigator (Helle Pappot, MD, DMSc)
Study leads

  • Helle Pappot, DMsc

    Principal Investigator

    Rigshospitalet, Denmark

View source on ClinicalTrials.gov(opens in a new tab)